A Drug-drug Interaction Study Of Fluzoparib (SHR3162) on Patients With Recurrent Ovarian Cancer

NCT04718740 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

33

Enrollment

INDUSTRY

Sponsor class

Conditions

Recurrent Ovarian Cancer

Interventions

DRUG: fluzoparib

Sponsor

Jiangsu HengRui Medicine Co., Ltd.